Wednesday Schedule

DNA’s 39th Annual Convention Schedule

Wednesday, April 21, 2021

8:00 am – 9:00 am EST

Exhibits

9:00 am – 10:00 am EST

Keynote/General Session 101
Topic/Title: Find Your Ahahaha Moments! And Unlock the Power of Humor

The Power of Humor – A funny, empowering, and interactive talk. NOT just another Power Point Presentation- Finally, somebody is doing a “Powerless Pointless Presentation” LOL. Humor, it’s not just for fun anymore!

The Keynote is sponsored by Castle BioSciences. You will hear from their Medical Director, Dr. Matthew Goldberg prior to the session.

Speaker: Nancy Norton, RN

10:00 am – 10:30 am EST

Exhibits/Break

10:30 am – 11:30 am EST

General Session 111
Topic/Title: Pediatric Dermatologic Emergencies

An irritable child, child that does not want to be carried, a subtle rash or eczema that is no longer responding to the daily treatments a can all be subtle signs of an impending pediatric dermatological emergency. Staphylococcal Scalded Skin Syndrome, eczema herpeticum, Stevens Johnson Syndrome, toxic epidermolysis bullosa, meningococcemia are all diagnoses that cause fear in pediatric nurses and providers. Knowing the subtle signs and symptoms of these conditions and others can expedite the parents ability to get the child optimal care. This presentation will provide clinical vignettes of pediatric patients and their clinical signs and symptoms of emergency pediatric dermatological conditions.

Speaker: Sandra Oehlke, RN, BSN, MAN, CPNP-PC, APRN, CCM, CCRP, CWOCN, DCNP

11:30 am – 11:45 am EST

Break

11:45 am – 12:45 pm EST

General Session 121
Topic/Title: Topic: It’s Not Just Diaper Rash

Just because the rash is in the diaper area does not mean it is just a diaper rash. Dermatology nurses and nurse practitioners are presented with patients with a diaper rash that is not responding to usual and customary treatments by the patient’s primary care provider. Irritant contact dermatitis, Jacquet’s dermatitis, allergic contact dermatitis, bacterial and fungal dermatitis, eczematous dermatitis and other forms of diaper dermatitis will be presented through patient vignettes.

Speaker: Sandra Oehlke, RN, BSN, MAN, CPNP-PC, APRN, CCM, CCRP, CWOCN, DCNP

12:45 pm – 1:00 pm EST

Break

1:00 pm – 2:00 pm EST

General Session 131
Topic/Title: A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis

Product Theater Sponsored by Regeneron/Sanofi Genzyme

Learn more about a treatment that may help your appropriate atopic dermatitis patients with uncontrolled moderate-to-severe atopic dermatitis.

No CE

Speaker: Sandri Johnson, MSN, FNP-BC

2:00 pm – 2:15 pm EST

Break

2:15 pm – 3:15 pm EST

General Session 141
Topic/Title: Optimizing Flow in Mohs Surgery During A Pandemic

Mohs Surgery needed to act quickly during the COVID pandemic in 2020 to reschedule and treat 600 plus skin cancers. There were several successful tactics that allowed this to happen in 1.5 months time and improved flow to the extent of being able to add additional cases daily.

Speaker: Haley Kovac, MSN, RN

3:15 pm – 3:45 pm EST

Exhibits/Break

3:45 pm – 4:45 pm EST

General Session 151
Topic/Title: Raising Awareness of Topical Steroid Withdrawal (TSW) Syndrome: Patient Impact and Caregiver Responsibility

Topical Steroid Withdrawal Syndrome is often mistaken for “worsening eczema”, contact dermatitis, or an allergic reaction. We need to prepare nurses to recognize TSW Syndrome risk factors during assessment, including which questions to ask during intake. Nurses also need to understand the protracted nature of this disease, and the importance of maintaining a working relationship with the patient, to best serve this often misunderstood, under served patient population. The tendency of this population to never return to the office after a negative interaction with medical staff can not be underestimated.

Speaker: Kathryn Z. Tullos, RN

4:45 pm – 5:00 pm EST

Break

5:00 pm – 6:00 pm EST

General Session 161
Product Theater: Incorporating Diagnostic & Prognostic Gene Expression Profile Tests in the Management of Skin Cancer

Sponsored by Castle BioSciences (no CE)

Speaker: Jennifer Tinkler, FNP-BC, DCNP

X